Yuan Zhu Selected Research

Central Nervous System Cavernous Hemangioma

4/2022	Cerebral cavernous malformations do not fall in the spectrum of PIK3CA-related overgrowth.
12/2020	DNA promoter methylation of CCM genes in human cerebral cavernous malformations: Importance of confirming MSP data through sequencing.
1/2017	Outcome after conservative management or surgical treatment for new-onset epilepsy in cerebral cavernous malformation.
1/2015	Regulation of β1 integrin-Klf2-mediated angiogenesis by CCM proteins.
9/2010	Susceptibility weighted magnetic resonance imaging of cerebral cavernous malformations: prospects, drawbacks, and first experience at ultra-high field strength (7-Tesla) magnetic resonance imaging.
7/2010	Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.
3/2009	Phosphatase and tensin homolog in cerebral cavernous malformation: a potential role in pathological angiogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yuan Zhu Research Topics

Disease

62	Neoplasms (Cancer) 01/2024 - 05/2004
17	Rectal Neoplasms (Rectal Cancer) 10/2023 - 03/2005
13	Lymphoma (Lymphomas) 01/2023 - 09/2015
11	Infections 04/2024 - 04/2007
10	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2020
10	Glioma (Gliomas) 01/2021 - 07/2002
9	Inflammation (Inflammations) 05/2024 - 10/2003
8	Glioblastoma (Glioblastoma Multiforme) 09/2023 - 10/2013
7	Central Nervous System Cavernous Hemangioma 04/2022 - 03/2009
7	T-Cell Lymphoma (Lymphoma, T Cell) 01/2021 - 09/2015
6	Neurofibromatosis 1 (Neurofibromatosis Type I) 10/2021 - 02/2008
5	Ischemic Stroke 05/2024 - 04/2021
5	Atherosclerosis 05/2024 - 12/2019
5	Fibrosis (Cirrhosis) 09/2023 - 01/2020
5	Neoplasm Metastasis (Metastasis) 06/2023 - 03/2003
5	Breast Neoplasms (Breast Cancer) 06/2023 - 09/2008
5	Body Weight (Weight, Body) 01/2022 - 03/2016
5	Astrocytoma (Pilocytic Astrocytoma) 10/2015 - 07/2002
4	Hemorrhage 07/2023 - 01/2021
4	Necrosis 02/2023 - 10/2013
4	Osteoarthritis 01/2023 - 11/2020
4	Adenocarcinoma 10/2021 - 12/2008
4	Hyperlipidemias (Hyperlipidemia) 01/2021 - 03/2016
3	Salmonella Infections (Salmonellosis) 04/2024 - 01/2021
3	Cognitive Dysfunction 11/2023 - 12/2022
3	Stroke (Strokes) 07/2023 - 02/2007
3	Ganglion Cysts (Ganglion) 01/2023 - 05/2013
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2023 - 01/2018
3	Atrophy 12/2022 - 01/2021
3	Parkinson Disease (Parkinson's Disease) 05/2022 - 02/2007
3	Wounds and Injuries (Trauma) 01/2022 - 05/2009
3	Medulloblastoma 01/2022 - 10/2018
3	Stomach Neoplasms (Stomach Cancer) 10/2021 - 01/2012
3	Virus Diseases (Viral Diseases) 10/2020 - 12/2015
3	Ischemia 04/2020 - 05/2001
3	Neurofibromatoses (Neurofibromatosis) 01/2018 - 02/2008
3	Arthritis (Polyarthritis) 01/2017 - 10/2003
3	Brain Ischemia (Cerebral Ischemia) 12/2014 - 08/2005
3	Carcinoma (Carcinomatosis) 04/2007 - 03/2003
2	Melanosis (Freckles) 05/2024 - 01/2024
2	Atherosclerotic Plaque (Atheroma) 05/2024 - 10/2020
2	Bacterial Infections (Bacterial Infection) 04/2024 - 01/2022
2	Ovarian Neoplasms (Ovarian Cancer) 01/2024 - 04/2015
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2023 - 01/2016
2	Osteoporosis 10/2023 - 01/2020
2	Nasopharyngeal Carcinoma 01/2023 - 01/2020
2	Hypertension (High Blood Pressure) 01/2023 - 01/2021
2	Tissue Adhesions 01/2023 - 01/2022

Drug/Important Bio-Agent (IBA)

18	Biomarkers (Surrogate Marker)IBA 01/2024 - 09/2011
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2002
7	Neurofibromin 1 (Neurofibromin)IBA 01/2018 - 07/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2023 - 08/2005
6	Retinaldehyde (Retinal)IBA 01/2023 - 05/2013
6	CholesterolIBA 01/2021 - 03/2016
5	Blood Glucose (Blood Sugar)IBA 05/2024 - 01/2021
5	LipidsIBA 05/2024 - 07/2020
5	Long Noncoding RNAIBA 01/2024 - 01/2019
5	AnthracyclinesIBA 01/2023 - 12/2018
5	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2022 - 02/2007
5	Messenger RNA (mRNA)IBA 01/2021 - 05/2001
4	Phosphotransferases (Kinase)IBA 04/2024 - 01/2019
4	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 02/2007
4	IronIBA 11/2023 - 09/2010
4	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2023 - 09/2015
4	MicroRNAs (MicroRNA)IBA 01/2023 - 10/2016
4	Capecitabine (Xeloda)FDA Link 01/2022 - 03/2015
3	MicellesIBA 02/2023 - 06/2010
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 10/2016
3	RNA (Ribonucleic Acid)IBA 06/2022 - 03/2017
3	Indicators and Reagents (Reagents)IBA 05/2022 - 10/2016
3	Temozolomide (Temodar)FDA LinkGeneric 04/2022 - 02/2016
3	Apolipoproteins E (ApoE)IBA 01/2022 - 07/2020
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2021 - 03/2015
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021 - 11/2016
3	Viral RNAIBA 01/2021 - 12/2015
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2021 - 12/2015
3	Therapeutic UsesIBA 11/2020 - 06/2008
3	ProdrugsIBA 10/2020 - 12/2016
3	Mitogen-Activated Protein KinasesIBA 01/2018 - 01/2017
3	AntioxidantsIBA 11/2016 - 04/2012
3	Oxygen (Dioxygen)IBA 12/2014 - 02/2007
2	AcidsIBA 03/2024 - 01/2019
2	Rituximab (Mabthera)FDA Link 11/2023 - 01/2016
2	Estrogens (Estrogen)FDA Link 10/2023 - 10/2003
2	CollagenIBA 01/2023 - 01/2020
2	Circular RNAIBA 01/2023 - 01/2023
2	Histone MethyltransferasesIBA 01/2023 - 11/2014
2	Mannose (D-Mannose)IBA 01/2023 - 01/2020
2	HydrogelsIBA 01/2023 - 01/2023
2	Cadherins (E-Cadherin)IBA 01/2023 - 03/2021

Therapy/Procedure

33	Therapeutics 05/2024 - 05/2004
23	Radiotherapy 01/2023 - 03/2003
16	Drug Therapy (Chemotherapy) 01/2023 - 03/2005
10	Chemoradiotherapy 01/2022 - 03/2005
8	Neoadjuvant Therapy 10/2023 - 03/2005
4	Microspheres (Microsphere) 01/2023 - 11/2020
3	Osteotomy 12/2018 - 06/2016
3	Oral Administration 11/2016 - 12/2005
3	Transplantation 02/2016 - 08/2005
2	Aftercare (After-Treatment) 05/2024 - 10/2016